Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection modelBrian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear CellsJulie B Dumond, Kuo H Yang, Racheal Kendrick, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Therapeutic Drug Monitoring|September 28, 2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoringJudianne Slish, Qing Ma, Barry S Zingman, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2017
Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection ModelYu-Wei Lin, Qi Tony Zhou, Mei-Ling Han, et al.
British Journal of Cancer|October 27, 2021
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patientsSpinel Karas, Amy S Etheridge, Deborah A Nickerson, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Population pharmacokinetics of oseltamivir: pediatrics through geriatricsMohamed A Kamal, Scott A Van Wart, Craig R Rayner, et al.
Journal of Clinical Pharmacology|January 7, 2011
Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Patcharaporn Sudchada, Kiran Dole, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|June 19, 2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection modelBrian Vanscoy, Rodrigo E Mendes, Mariana Castanheira, et al.
Antimicrobial Agents and Chemotherapy|August 5, 2015
Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear CellsJulie B Dumond, Kuo H Yang, Racheal Kendrick, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Clinical population pharmacokinetics and toxicodynamics of linezolidLauren M Boak, Craig R Rayner, M Lindsay Grayson, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Therapeutic Drug Monitoring|September 28, 2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoringJudianne Slish, Qing Ma, Barry S Zingman, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2017
Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection ModelYu-Wei Lin, Qi Tony Zhou, Mei-Ling Han, et al.
British Journal of Cancer|October 27, 2021
Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patientsSpinel Karas, Amy S Etheridge, Deborah A Nickerson, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Population pharmacokinetics of oseltamivir: pediatrics through geriatricsMohamed A Kamal, Scott A Van Wart, Craig R Rayner, et al.
Journal of Clinical Pharmacology|January 7, 2011
Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Patcharaporn Sudchada, Kiran Dole, et al.
Pageof 18